Mga Batayang Estadistika
| CIK | 1822935 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Healthcare Capital Corp - Class A
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 14, 2023 |
SC 13G/A 1 cohenco-hccc123122a1.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 42228C101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Stateme |
|
| March 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39893 Healthcare Capita |
|
| March 31, 2022 |
DESCRIPTION OF REGISTRANT’S SECURITIES Exhibit 4.5 DESCRIPTION OF REGISTRANT?S SECURITIES The following summary of Healthcare Capital Corp?s securities is based on and qualified by the Company?s Amended and Restated Articles of Incorporation (the ?Amended and Restated Charter?). References to the ?Company? and to ?we,? ?us,? and ?our? refer to Healthcare Capital Corp. This summary refers to the terms of the securities in place prior to |
|
| March 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-39893 HEALTHCARE CAPITAL CORP. (Exact name of registrant as specified i |
|
| March 9, 2022 |
SC 13G/A 1 ea156618-13ga1sponsorhealth.htm AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $.0001 per share (Title of Class of Securities) 42228C101 (CUSIP Number) December 31, 2021 (Date of Event |
|
| March 8, 2022 |
SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. Exhibit 3.1 SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. FIRST: The name of the corporation is Healthcare Capital Corp. (the ?Corporation?). SECOND: The address of the Corporation?s registered office in the State of Delaware is 1209 Orange Street, in the City of Wilmington, County of New Castle, 19801. The name of its registered agent at such address is The |
|
| March 8, 2022 |
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination Exhibit 99.1 Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination Alpha Tau Is Expected to Commence Trading on Nasdaq Under the Ticker ?DRTS? on March 8, 2022 JERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ - Alpha Tau Medical Ltd. (?Alpha Tau?), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT?, and Healthcare Capital Corp. |
|
| March 8, 2022 |
AMENDED & RESTATED WARRANT AGREEMENT Exhibit 4.1 AMENDED & RESTATED WARRANT AGREEMENT THIS AMENDED & RESTATED WARRANT AGREEMENT (this ?Agreement?), dated as of March 7, 2022, is by and between Alpha Tau Medical Ltd., a company organized under the laws of the State of Israel (the ?Company?), Healthcare Capital Corp., a Delaware corporation (?HCCC?), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant age |
|
| March 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 7, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commission |
|
| February 22, 2022 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 22, 2022 (February 18, 2022) Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of inc |
|
| February 22, 2022 |
EX-99.1 2 ea156028ex99-1healthcare.htm PRESS RELEASE OF ALPHA TAU MEDICAL LTD., DATED FEBRUARY 22, 2022 Exhibit 99.1 Healthcare Capital Corp. and Alpha Tau Medical Ltd. Announce Stockholder Approval of the Business Combination NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) - Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) and Alpha Tau Medical Ltd. (“Alpha Tau”) |
|
| February 18, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 (Title of Class of Securities) 42228C101 (CUSIP Number) February 9, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the r |
|
| February 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| February 18, 2022 |
Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders Exhibit 99.1 Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders NEW YORK, NY ?? February 18, 2022 ?? Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (?HCCC?) today announced that on February 18, 2022, it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the ?Special Meeting?). The Special Meeting has be |
|
| February 18, 2022 |
Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders Exhibit 99.1 Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders NEW YORK, NY ?? February 18, 2022 ?? Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (?HCCC?) today announced that on February 18, 2022, it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the ?Special Meeting?). The Special Meeting has be |
|
| February 17, 2022 |
Exhibit 10.1 Execution Version HEALTHCARE CAPITAL SPONSOR LLC 301 North Market Street Suite 1414 Wilmington, DE 19801 February 17, 2022 Healthcare Capital Corp. 301 North Market Street Suite 1414 Wilmington, DE 19801 Attention: William Johns, CEO Email: [email protected] Alpha Tau Medical Ltd. Kiryat HaMada St 5 Jerusalem, 9777605, Israel Attention: Uzi Sofer, CEO Email: [email protected] |
|
| February 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 17, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| February 17, 2022 |
Exhibit 10.1 Execution Version HEALTHCARE CAPITAL SPONSOR LLC 301 North Market Street Suite 1414 Wilmington, DE 19801 February 17, 2022 Healthcare Capital Corp. 301 North Market Street Suite 1414 Wilmington, DE 19801 Attention: William Johns, CEO Email: [email protected] Alpha Tau Medical Ltd. Kiryat HaMada St 5 Jerusalem, 9777605, Israel Attention: Uzi Sofer, CEO Email: [email protected] |
|
| February 17, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 17, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| February 15, 2022 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 15, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| February 15, 2022 |
Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders Exhibit 99.1 Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders NEW YORK, NY, Feb. 15, 2022 (GLOBE NEWSWIRE) - Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (?HCCC?) today announced that on February 15, 2022 it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the ?Special Meeting?). The Special Meeti |
|
| February 15, 2022 |
Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders Exhibit 99.1 Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders NEW YORK, NY, Feb. 15, 2022 (GLOBE NEWSWIRE) - Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (?HCCC?) today announced that on February 15, 2022 it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the ?Special Meeting?). The Special Meeti |
|
| February 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 15, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $.0001 per share (Title of Class of Securities) 42228C101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desig |
|
| February 11, 2022 |
EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. |
|
| February 11, 2022 |
EXHIBIT 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENT, that I, Michael Edward Platt, hereby make, constitute and appoint Steven Pariente, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as principal of, or in other capacities with, BlueCrest Capital Management Limited, a company organized under the |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 42228C101 (CUSIP Number) 31 December 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 11, 2022 |
=============================================================================== UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| February 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $.0001 per share (Title of Class of Securities) 42228C101 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to desi |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| January 20, 2022 |
Filed by Healthcare Capital Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Alpha Tau Medical Ltd. Commission File No.: 333-258915 Date: January 20, 2022 Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRTTM to Enhance Immune Stimulation in the Treatment o |
|
| January 19, 2022 |
Exhibit 99.1 Healthcare Capital Corp Announces Special Meeting Date for Proposed Business Combination with Alpha Tau Medical Ltd. Special Meeting Scheduled for February 15, 2022 The combined company will be named Alpha Tau Medical Ltd. and remain listed on the NASDAQ under ticker DRTS NEW YORK, New York and JERUSALEM, Israel, Jan. 19, 2022 (GLOBE NEWSWIRE) - Healthcare Capital Corp (NASDAQ: HCCC, |
|
| January 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 19, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commissi |
|
| January 19, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 19, 2022 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commissi |
|
| January 19, 2022 |
Exhibit 99.1 Healthcare Capital Corp Announces Special Meeting Date for Proposed Business Combination with Alpha Tau Medical Ltd. Special Meeting Scheduled for February 15, 2022 The combined company will be named Alpha Tau Medical Ltd. and remain listed on the NASDAQ under ticker DRTS NEW YORK, New York and JERUSALEM, Israel, Jan. 19, 2022 (GLOBE NEWSWIRE) - Healthcare Capital Corp (NASDAQ: HCCC, |
|
| January 14, 2022 |
Table of Contents SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| January 12, 2022 |
Filed by Alpha Tau Medical Ltd. Filed by Alpha Tau Medical Ltd. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Healthcare Capital Corp. Commission File No. 001-39893 Date: January 12, 2022 Company Overview Disclaimer This presentation (together with oral statements made in connection herewith, the Presentation ) is for info |
|
| January 10, 2022 |
Filed by Healthcare Capital Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Alpha Tau Medical Ltd. Commission File No.: 333-258915 Date: January 10, 2022 Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT? in Malignant Skin & Soft Tissue Cancers, Showing Complete Respon |
|
| January 3, 2022 |
Filed by Healthcare Capital Corp. Filed by Healthcare Capital Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Alpha Tau Medical Ltd. Commission File No.: 333-258915 Date: January 3, 2022 Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer JERUSALEM, Jan. 3, 2022 |
|
| December 14, 2021 |
HCCC / Healthcare Capital Corp / Atalaya Capital Management LP Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 4228C200** (CUSIP Number) October 1, 2021*** (Date of Event which Requires Filing of this Statement) Check the appropriate box to d |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 15, 2021 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commiss |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39893 Healthcare Capita |
|
| November 3, 2021 |
425 1 ea149862-425healthcarecap.htm 425 Filed by Healthcare Capital Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Alpha Tau Medical Ltd. Commission File No.: 333-258915 Date: November 3, 2021 Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembro |
|
| October 25, 2021 |
Filed by Healthcare Capital Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Alpha Tau Medical Ltd. Commission File No.: 333-258915 Date: October 25, 2021 Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT? and Achievement of First Primary Objective JERU |
|
| October 13, 2021 |
Alpha Tau Receives FDA’s Breakthrough Device Designation for the Treatment of Recurrent GBM 425 1 ea148721-425healthcare.htm FORM 425 Filed by Healthcare Capital Corp. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Alpha Tau Medical Ltd. Commission File No.: 333-258915 Date: October 12, 2021 Alpha Tau Receives FDA’s Breakthrough Device Designation for the Treatment of Recurrent GBM |
|
| August 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39893 Healthcare Capital Cor |
|
| August 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-K ? Transition Report on Fo |
|
| July 8, 2021 |
Exhibit 10.2 FORM OF SUPPORT AGREEMENT This Support Agreement (this ?Agreement?) is made as of July 7, 2021 by and among (i) Healthcare Capital Corp., a Delaware corporation (?SPAC?), (ii) Alpha Tau Medical Ltd., a company organized under the laws of the State of Israel (the ?Company?), and (iii) the undersigned shareholder (?Holder?) of the Company. Any capitalized term used but not defined in th |
|
| July 8, 2021 |
Exhibit 99.2 1 Company Overview 2 This presentation (together with oral statements made in connection herewith, the "Presentation") is for informational purpos es only to assist interested parties in making their own evaluation with respect to the proposed business combination (the "Business Combination") between Healthcare Capital Corp. (?HCCC?) and Alpha Tau Medical Ltd. (?Alpha Tau? or th e ?Co |
|
| July 8, 2021 |
Filed by Alpha Tau Medical Ltd. Filed by Alpha Tau Medical Ltd. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Healthcare Capital Corp. Commission File No. 001-39893 Date: July 8, 2021 Company Overview July 2021 This presentation (together with oral statements made in connection herewith, the "Presentation") is for informat |
|
| July 8, 2021 |
Exhibit 99.1 Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation - Alpha Tau?s proprietary Alpha DaRT? is designed to deliver uniquely potent alpha radiation to destroy solid tumors with localized precision, sparing surrounding healthy tissue, thereby maintaini |
|
| July 8, 2021 |
Exhibit 10.1 July 7, 2021 Healthcare Capital Corp. 301 North Market Street Suite 1414 Wilmington, DE 19801 Attention: William Johns, CEO Email: [email protected] Alpha Tau Medical Ltd. Kiryat HaMada St 5 Jerusalem, 9777605, Israel Attention: Uzi Sofer, CEO Email: [email protected] Re: Sponsor Support Agreement Ladies and Gentlemen: This letter agreement (this ?Sponsor Agreement?) is being |
|
| July 8, 2021 |
Exhibit 10.1 July 7, 2021 Healthcare Capital Corp. 301 North Market Street Suite 1414 Wilmington, DE 19801 Attention: William Johns, CEO Email: [email protected] Alpha Tau Medical Ltd. Kiryat HaMada St 5 Jerusalem, 9777605, Israel Attention: Uzi Sofer, CEO Email: [email protected] Re: Sponsor Support Agreement Ladies and Gentlemen: This letter agreement (this ?Sponsor Agreement?) is being |
|
| July 8, 2021 |
Filed by Alpha Tau Medical Ltd. 425 1 d171522d425.htm 425 Filed by Alpha Tau Medical Ltd. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Healthcare Capital Corp. Commission File No. 001-39893 Date: July 8, 2021 Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the |
|
| July 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2021 (July 7, 2021) Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation |
|
| July 8, 2021 |
Exhibit 99.2 1 Company Overview 2 This presentation (together with oral statements made in connection herewith, the "Presentation") is for informational purpos es only to assist interested parties in making their own evaluation with respect to the proposed business combination (the "Business Combination") between Healthcare Capital Corp. (?HCCC?) and Alpha Tau Medical Ltd. (?Alpha Tau? or th e ?Co |
|
| July 8, 2021 |
Exhibit 10.2 FORM OF SUPPORT AGREEMENT This Support Agreement (this ?Agreement?) is made as of July 7, 2021 by and among (i) Healthcare Capital Corp., a Delaware corporation (?SPAC?), (ii) Alpha Tau Medical Ltd., a company organized under the laws of the State of Israel (the ?Company?), and (iii) the undersigned shareholder (?Holder?) of the Company. Any capitalized term used but not defined in th |
|
| July 8, 2021 |
Exhibit 2.1 CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among ALPHA TAU MEDICAL LTD. ARCHERY MERGER SUB INC. and HEALTHCARE CAPITAL CORP. dated as of July 7, 2021 This document is intended solely to facilitate discussions and negotiation among the parties identified herein. It is not intended to create, and it will not be deemed to create, any legally binding or enforceable offer or agreement |
|
| July 8, 2021 |
Exhibit 2.1 CONFIDENTIAL AGREEMENT AND PLAN OF MERGER by and among ALPHA TAU MEDICAL LTD. ARCHERY MERGER SUB INC. and HEALTHCARE CAPITAL CORP. dated as of July 7, 2021 This document is intended solely to facilitate discussions and negotiation among the parties identified herein. It is not intended to create, and it will not be deemed to create, any legally binding or enforceable offer or agreement |
|
| July 8, 2021 |
EX-99.1 5 ea143907ex99-1healthcare.htm PRESS RELEASE, DATED JULY 8, 2021 Exhibit 99.1 Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation - Alpha Tau’s proprietary Alpha DaRT™ is designed to deliver uniquely potent alpha radiation to destroy solid tumors with l |
|
| July 8, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 8, 2021 (July 7, 2021) Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation |
|
| June 4, 2021 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 28, 2021 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commission F |
|
| June 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39893 Healthcare Capital Co |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING Commission File Number: 001-39893 (Check one): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on |
|
| April 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39893 Healthcare Capita |
|
| April 15, 2021 |
Description of Registered Securities.* Exhibit 4.5 DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED As of January 13, 2020, Healthcare Capital Corp. (?we,? ?our,? ?us? or the ?company?) had the following three classes of securities registered under Section 12 of the Exchange Act: (i) its units, consisting of one share of Class A common stock (as defined belo |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2020 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-K ? Transition Report o |
|
| March 4, 2021 |
Healthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and Warrants EX-99.1 2 ea137053ex99-1healthcare.htm PRESS RELEASE DATED MARCH 4, 2021 Exhibit 99.1 Healthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Wilmington, DE March 4, 2021 – Healthcare Capital Corp. (the “Company”) announced today that, commencing March 8, 2021, holders of the 27,500,000 units sold in the Company’s initial public offering may elect to separa |
|
| March 4, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 4, 2021 HEALTHCARE CAPITAL CORP. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commission |
|
| January 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 42228C200** (CUSIP Number) 20 January 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| January 29, 2021 |
SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Healthcare Capital Corp. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 42228C200 (CUSIP Number) January 20, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| January 29, 2021 |
EX-99.A 2 d105836dex99a.htm EX-99.A Page 9 of 9 EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock of Healthcare Capital Corp. dated as of January 20, 2021 is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of |
|
| January 29, 2021 |
EXHIBIT 2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENT, that I, Michael Edward Platt, hereby make, constitute and appoint Steven Pariente, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as principal of, or in other capacities with, BlueCrest Capital Management Limited, a company organized under the |
|
| January 29, 2021 |
EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. |
|
| January 26, 2021 |
HEALTHCARE CAPITAL CORP. INDEX TO FINANCIAL STATEMENT Exhibit 99.1 HEALTHCARE CAPITAL CORP. INDEX TO FINANCIAL STATEMENT Page Audited Financial Statements of Healthcare Capital Corp.: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of January 20, 2021 F-3 Notes to Financial Statement F-4 F-1 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and the Board of Directors of Healthcare Capital Corp. O |
|
| January 26, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 20, 2021 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commissi |
|
| January 21, 2021 |
EX-4.1 4 ea133630ex4-1healthcare.htm WARRANT AGREEMENT, DATED JANUARY 14, 2021, BY AND BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT Exhibit 4.1 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of January 14, 2021, is by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Co |
|
| January 21, 2021 |
Healthcare Capital Corp. Announces Closing of Upsized $275,000,000 Initial Public Offering Exhibit 99.2 Healthcare Capital Corp. Announces Closing of Upsized $275,000,000 Initial Public Offering Wilmington, DE, January 20, 2021 (GLOBE NEWSWIRE) – Healthcare Capital Corp. (the “Company”) announced today that it closed its upsized initial public offering of 27,500,000 units at $10.00 per unit, including 3,500,000 units issued pursuant to an exercise by the underwriters of their over-allot |
|
| January 21, 2021 |
Healthcare Capital Corp. Announces Pricing of Upsized $240 Million Initial Public Offering Exhibit 99.1 Healthcare Capital Corp. Announces Pricing of Upsized $240 Million Initial Public Offering Healthcare Capital Corp. (the “Company”), a newly incorporated blank check company, today announced the pricing of its upsized initial public offering of 24,000,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under th |
|
| January 21, 2021 |
Amended and Restated Certificate of Incorporation. EX-3.1 3 ea133630ex3-1healthcare.htm AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. January 14, 2021 Healthcare Capital Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Healthcare Capi |
|
| January 21, 2021 |
Exhibit 1.1 UNDERWRITING AGREEMENT between HEALTHCARE CAPITAL CORP. and CANTOR FITZGERALD & CO. Dated January 14, 2021 1 HEALTHCARE CAPITAL CORP. UNDERWRITING AGREEMENT New York, New York January 14, 2021 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Healthcare Capital Corp., |
|
| January 21, 2021 |
Exhibit 10.5 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of January 14, 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and Healthcare Capital Sponsor LLC, a Delaware limited lia |
|
| January 21, 2021 |
EX-10.2 6 ea133630ex10-2healthcare.htm INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 14, 2021, BY AND BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS TRUSTEE Exhibit 10.2 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of January 14, 2021, by and between Healthcare Capital Corp., a Delaware corpo |
|
| January 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2021 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 001-39893 85-2609863 (State or other jurisdiction of incorporation) (Commissi |
|
| January 21, 2021 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of January 14, 2021, is made and entered into by and among Healthcare Capital Corp., a Delaware corporation (the “Company”), Healthcare Capital Sponsor LLC, a Delaware limited liability company (the “Sponsor”; together with any person or entity who hereafter becomes a party to this Agreement |
|
| January 21, 2021 |
Exhibit 10.4 HEALTHCARE CAPITAL CORP. 301 North Market Street, Suite 1414 Wilmington, DE 19801 January 14, 2021 HEALTHCARE CAPITAL SPONSOR LLC 301 North Market Street, Suite 1414 Wilmington, DE 19801 Re: Administrative Support Agreement Ladies and Gentlemen: This letter agreement by and between Healthcare Capital Corp. (the “Company”) and Healthcare Capital Sponsor LLC (the “Sponsor”), dated as of |
|
| January 21, 2021 |
Exhibit 10.1 January 14, 2021 Healthcare Capital Corp. 301 North Market Street, Suite 1414 Wilmington, DE 19801 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and |
|
| January 20, 2021 |
$240,000,000 Healthcare Capital Corp. 24,000,000 Units PROSPECTUS Filed Pursuant to Rule 424(b)(4) Registration Nos. 333-251527 and 333-252114 $240,000,000 Healthcare Capital Corp. 24,000,000 Units Healthcare Capital Corp. is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we r |
|
| January 14, 2021 |
As filed with the U.S. Securities and Exchange Commission on January 14, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 6770 85-2609863 (State or Other Jurisdiction of Incorporation or Organizat |
|
| January 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Healthcare Capital Corp. (Exact Name of Registrant as Specified in Its Charter) Delaware 85-2609863 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) 301 North Market |
|
| January 13, 2021 |
S-1/A 1 fs12020a2healthcarecapital.htm AMENDMENT NO. 2 TO FORM S-1 As filed with the U.S. Securities and Exchange Commission on January 13, 2021. Registration No. 333-251527 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Capital Corp. (Exact name of registrant as specified in its |
|
| January 13, 2021 |
January 13, 2021 VIA EDGAR U.S. Securities & Exchange Commission 100 F Street, NE Washington, D.C. 20549-4561 Re: Healthcare Capital Corp. Registration Statement on Form S-1 Filed December 21, 2020, as amended File No. 333-251527 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the ?Act?), the undersigned hereby joins in |
|
| January 13, 2021 |
Healthcare Capital Corp. 301 North Market Street Suite 1414 Wilmington, DE 19801 VIA EDGAR January 13, 2021 U.S. Securities & Exchange Commission Division of Corporation Finance Office of Energy and Transportation 100 F Street, NE Washington, D.C. 20549 Attn: Jeffrey Lewis Re: Healthcare Capital Corp. Registration Statement on Form S-1 Filed December 21, 2020 File No. 333-251527 Dear Mr. Lewis: He |
|
| January 13, 2021 |
Healthcare Capital Corp. c/o Ellenoff Grossman & Schole LLP 301 North Market Street Suite 1414 Wilmington, DE 19801 January 13, 2021 VIA EDGAR U.S. Securities and Exchange Commission 100 F Street, N.E. Mail Stop 3030 Washington, D.C. 20549 Attention: Jeffrey Lewis Re: Healthcare Capital Corp. Registration Statement on Form S-1, as amended Filed December 21, 2020 File No. 333-251527 Dear Ms. Lewis: |
|
| January 11, 2021 |
Exhibit 10.8 HEALTHCARE CAPITAL CORP. 301 North Market Street, Suite 1414 Wilmington, DE 19801 [ ], 2021 HEALTHCARE CAPITAL SPONSOR LLC 301 North Market Street, Suite 1414 Wilmington, DE 19801 Re: Administrative Support Agreement Ladies and Gentlemen: This letter agreement by and between Healthcare Capital Corp. (the “Company”) and Healthcare Capital Sponsor LLC (the “Sponsor”), dated as of the da |
|
| January 11, 2021 |
Form of Registration Rights Agreement between the Registrant and certain security holders* Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [ ], 2021, is made and entered into by and among Healthcare Capital Corp., a Delaware corporation (the “Company”), Healthcare Capital Sponsor LLC, a Delaware limited liability company (the “Sponsor”; together with any person or entity who hereafter becomes a party to this Agreement pursuan |
|
| January 11, 2021 |
EX-99.5 21 fs12020a1ex99-5healthcare.htm CONSENT OF BRUCE ROBERTS Exhibit 99.5 CONSENT OF BRUCE ROBERTS Healthcare Capital Corp. intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto the “Registration Statement”), registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amend |
|
| January 11, 2021 |
EX-99.3 19 fs12020a1ex99-3healthcare.htm CONSENT OF THOMAS INSEL Exhibit 99.3 CONSENT OF THOMAS INSEL Healthcare Capital Corp. intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto the “Registration Statement”), registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended |
|
| January 11, 2021 |
Form of Amended and Restated Certificate of Incorporation* EX-3.2 3 fs12020a1ex3-2healthcare.htm AMENDED AND RESTATED CERTIFICATE OF INCORPORATION Exhibit 3.2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. December 22, 2020 Healthcare Capital Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The name of the Corporation is “Healthcare Ca |
|
| January 11, 2021 |
Exhibit 99.4 CONSENT OF PETER KASH Healthcare Capital Corp. intends to file a Registration Statement on Form S-1 (together with any amendments or supplements thereto the “Registration Statement”), registering securities for issuance in its initial public offering. As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registratio |
|
| January 11, 2021 |
Form of Underwriting Agreement* Exhibit 1.1 UNDERWRITING AGREEMENT between HEALTHCARE CAPITAL CORP. and CANTOR FITZGERALD & CO. Dated [], 2021 1 HEALTHCARE CAPITAL CORP. UNDERWRITING AGREEMENT New York, New York [], 2021 Cantor Fitzgerald & Co. 499 Park Avenue New York, New York 10022 As Representative of the Underwriters named on Schedule A hereto Ladies and Gentlemen: The undersigned, Healthcare Capital Corp., a Delaware corpo |
|
| January 11, 2021 |
Healthcare Capital Corp. 301 North Market Street Suite 1414 Wilmington, DE 19801 VIA EDGAR January 11, 2021 U.S. Securities & Exchange Commission Division of Corporation Finance Office of Energy and Transportation 100 F Street, NE Washington, D.C. 20549 Attn: Jeffrey Lewis Re: Healthcare Capital Corp. Registration Statement on Form S-1 Filed December 21, 2020 File No. 333-251527 Dear Mr. Lewis: He |
|
| January 11, 2021 |
Exhibit 10.7 FORM OF INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [ ], 2021, by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and (“Indemnitee”). RECITALS WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers or in other capacities unless they are provided with adequat |
|
| January 11, 2021 |
Exhibit 4.1 NUMBER UNITS U- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 4228C 200 HEALTHCARE CAPITAL CORP. UNITS CONSISTING OF ONE SHARE OF CLASS A COMMON STOCK AND ONE-HALF OF ONE WARRANT, EACH WHOLE WARRANT ENTITLING THE HOLDER TO PURCHASE ONE SHARE OF CLASS A COMMON STOCK THIS CERTIFIES THAT is the owner of Units. Each Unit (“Unit”) consists of one (1) share of Class A common stock, par value $0. |
|
| January 11, 2021 |
Form of Audit Committee Charter* Exhibit 99.1 HEALTHCARE CAPITAL CORP. AUDIT COMMITTEE CHARTER 1. STATUS The Audit Committee (the “Committee”) is a committee of the Board of Directors (the “Board”) of Healthcare Capital Corp. (the “Company”). 2. PURPOSE The Committee is appointed by the Board for the primary purposes of: ● Performing the Board’s oversight responsibilities as they relate to the Company’s accounting policies and in |
|
| January 11, 2021 |
As filed with the U.S. Securities and Exchange Commission on January 11, 2021. Registration No. 333-251527 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 6770 85-2609863 (State or other jurisdiction of |
|
| January 11, 2021 |
Specimen Class A Common Stock Certificate* Exhibit 4.2 NUMBER NUMBER C- SHARES SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP 4228C 101 HEALTHCARE CAPITAL CORP. INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE CLASS A COMMON STOCK This Certifies that is the owner of FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $0.0001 EACH OF THE CLASS A COMMON STOCK OF HEALTHCARE CAPITAL CORP. (THE “COMPANY”) transferable on the books of the Co |
|
| January 11, 2021 |
EX-14 15 fs12020a1ex14healthcare.htm CODE OF ETHICS Exhibit 14 CODE OF ETHICS OF HEALTHCARE CAPITAL CORP. 1. Introduction The Board of Directors (the “Board”) of Healthcare Capital Corp. has adopted this code of ethics (this “Code”), as amended from time to time by the Board and which is applicable to all of the Company’s directors, officers and employees to: ● promote honest and ethical conduct, |
|
| January 11, 2021 |
Exhibit 4.3 [Form of Warrant Certificate] [FACE] Number Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW HEALTHCARE CAPITAL CORP. Incorporated Under the Laws of the State of Delaware CUSIP 4228C 119 Warrant Certificate This Warrant Certificate certifies that , or registered assigns, is the regi |
|
| January 11, 2021 |
Form of Compensation Committee Charter* Exhibit 99.2 CHARTER OF THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS OF HEALTHCARE CAPITAL CORP. I. PURPOSE OF THE COMMITTEE The purposes of the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of Healthcare Capital Corp. (the “Company”) shall be to oversee the Company’s compensation and employee benefit plans and practices, including its executive compensat |
|
| January 11, 2021 |
Exhibit 10.6 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [ ], 2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered into by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and Healthcare Capital Sponsor LLC, a Delaware limited liability |
|
| January 11, 2021 |
EX-10.1 9 fs12020a1ex10-1healthcare.htm LETTER AGREEMENT Exhibit 10.1 [ ], 2021 Healthcare Capital Corp. 301 North Market Street, Suite 1414 Wilmington, DE 19801 Re: Initial Public Offering Ladies and Gentlemen: This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Healthcare Capital |
|
| January 11, 2021 |
EX-4.4 7 fs12020a1ex4-4healthcare.htm WARRANT AGREEMENT Exhibit 4.4 WARRANT AGREEMENT THIS WARRANT AGREEMENT (this “Agreement”), dated as of [ ], 2021, is by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”). WHE |
|
| January 11, 2021 |
EX-10.3 10 fs12020a1ex10-3healthcare.htm TRUST AGREEMENT Exhibit 10.3 INVESTMENT MANAGEMENT TRUST AGREEMENT This Investment Management Trust Agreement (this “Agreement”) is made effective as of [ ], 2021, by and between Healthcare Capital Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”). WHEREAS, the Company’s reg |
|
| December 21, 2020 |
Exhibit 3.1 CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. August 18, 2020 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the “Certificate”), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is Healthcare Capital Corp. (the “Corporation”). ARTI |
|
| December 21, 2020 |
Exhibit 10.5 Healthcare Capital Corp. Farmers Bank Building 301 North Market Street, Suite 1414 Wilmington, DE 19801 September 2, 2020 Healthcare Capital Sponsor LLC 301 North Market Street, Suite 1414 Wilmington, DE 19801 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (the “Agreement”) is entered into on September 2, 2020 by and between Healthcare Capital Sponsor LLC, |
|
| December 21, 2020 |
Registration Statement - REGISTRATION STATEMENT As filed with the U.S. Securities and Exchange Commission on December 18, 2020. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Capital Corp. (Exact name of registrant as specified in its charter) Delaware 6770 85-2609863 (State or other jurisdiction of incorporation or organiz |
|
| December 21, 2020 |
Exhibit 3.3 BYLAWS OF HEALTHCARE CAPITAL CORP. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s registered agent in Delawar |
|
| December 21, 2020 |
Promissory Note, dated September 2, 2020, issued to Healthcare Capital Sponsor LLC* Exhibit 10.2 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| October 13, 2020 |
This is a confidential draft submission to the U.S. Securities and Exchange Commission on October 9, 2020 and is not being filed under the Securities Act of 1933, as amended. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Healthcare Capital Corp. (Exact name of registrant as specified in |
|
| October 13, 2020 |
HEALTHCARE CAPITAL CORP. (THE “CORPORATION”) ARTICLE I Exhibit 3.3 BYLAWS OF HEALTHCARE CAPITAL CORP. (THE “CORPORATION”) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (b) the office of the corporation or individual acting as the Corporation’s registered agent in Delawar |
|
| October 13, 2020 |
CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. August 18, 2020 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF HEALTHCARE CAPITAL CORP. August 18, 2020 The undersigned, for the purposes of forming a corporation under the laws of the State of Delaware, does make, file, and record this Certificate of Incorporation (the “Certificate”), and does hereby certify as follows: ARTICLE I NAME The name of the corporation is Healthcare Capital Corp. (the “Corporation”). ARTI |
|
| October 13, 2020 |
Exhibit 10.2 THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY |
|
| October 13, 2020 |
Exhibit 10.5 Healthcare Capital Corp. Farmers Bank Building 301 North Market Street, Suite 1414 Wilmington, DE 19801 September 2, 2020 Healthcare Capital Sponsor LLC 301 North Market Street, Suite 1414 Wilmington, DE 19801 RE: Securities Subscription Agreement Ladies and Gentlemen: This agreement (the “Agreement”) is entered into on September 2, 2020 by and between Healthcare Capital Sponsor LLC, |
